Lime Pharma ApS Financials, key figures and credit report
Gross profit 68.3 kDKK FY 2025 -15.3% vs 2024
EBIT 68.3 kDKK FY 2025 +13.3% vs 2024
Net debt 430.4 kDKK FY 2025 -3.3% vs 2024
Quick ratio 0.7 FY 2025 +0 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 223.22 | 358.22 | 39.93 | 80.61 | 68.31 |
| Employee benefit expenses | - 321.25 | -0.87 | -20.33 | ||
| EBIT | 223.22 | 36.97 | 39.06 | 60.28 | 68.31 |
| Other financial income | 0.06 | 0.03 | |||
| Other financial expenses | -5.91 | -12.15 | -51.04 | -34.07 | -33.52 |
| Net income from associates (fin.) | -13.67 | 19.11 | -21.66 | 41.07 | |
| Pre-tax profit | 203.64 | 43.93 | -33.63 | 67.34 | 34.83 |
| Income taxes | -51.43 | -21.88 | -7.53 | -7.97 | -10.98 |
| Net earnings | 152.21 | 22.04 | -41.17 | 59.37 | 23.84 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Holdings in group member companies | 38.11 | 57.22 | 35.57 | 76.64 | |
| Investments total | 64.27 | 83.38 | 61.73 | 102.80 | 26.16 |
| Long term receivables total | |||||
| Finished products/goods | 285.00 | 307.61 | 263.85 | 120.82 | 156.26 |
| Inventories total | 285.00 | 307.61 | 263.85 | 120.82 | 156.26 |
| Current trade debtors | 146.98 | 148.52 | 142.75 | 261.91 | 311.09 |
| Prepayments and accrued income | 18.48 | 15.25 | 16.28 | 15.79 | 0.97 |
| Current other receivables | 70.99 | 32.30 | 58.05 | 38.09 | 98.92 |
| Current deferred tax assets | 10.69 | 11.92 | |||
| Short term receivables total | 236.45 | 196.07 | 227.77 | 327.71 | 410.99 |
| Cash and bank deposits | 188.94 | 149.06 | 83.76 | 80.25 | 87.92 |
| Cash and cash equivalents | 188.94 | 149.06 | 83.76 | 80.25 | 87.92 |
| Balance sheet total (assets) | 774.66 | 736.12 | 637.11 | 631.58 | 681.33 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | - 251.08 | -98.87 | -76.83 | - 117.99 | - 135.26 |
| Profit of the financial year | 152.21 | 22.04 | -41.17 | 59.37 | 23.84 |
| Shareholders equity total | -48.87 | -26.83 | -67.99 | -8.62 | -61.42 |
| Provisions | 4.07 | 3.35 | 3.58 | 3.47 | 0.21 |
| Non-current liabilities total | |||||
| Current trade creditors | 315.44 | 128.61 | 157.27 | 108.04 | 201.38 |
| Current owed to participating | 123.42 | 528.14 | 525.34 | 518.32 | |
| Short-term deferred tax liabilities | 50.71 | 12.60 | 2.24 | ||
| Other non-interest bearing current liabilities | 453.31 | 494.96 | 16.11 | 3.35 | 20.60 |
| Current liabilities total | 819.46 | 759.59 | 701.52 | 636.73 | 742.54 |
| Balance sheet total (liabilities) | 774.66 | 736.12 | 637.11 | 631.58 | 681.33 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated